Phibro Animal Health Corporation Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Phibro Animal Health (PAHC) Tops Q1 EPS by 7c, Revenues Beat; Offers 2Q Revenue Guidance Below Consensus, 2Q EPS Mid-Point Guidance Below Consensus
February 3, 2021 4:48 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $206 million versus the consensus estimate of $205.48 million.
Highlights for the December 31, 2020 quarter (compared to the quarter ended December 31, 2019)
Net sales of $206 million, a decrease of $8 million, or 4%Net income of $13 million, an increase of $1 million, or 8%Diluted EPS of $0.32, an increase of $0.03, or 10%.Adjusted EBITDA of $29... More